Significance of pharmacokinetics for the therapeutic practice
Casopis Lekaru Ceskych 118(4): 126-127
1979
ISSN/ISBN: 0008-7335 PMID: 427870 Document Number: 148949
Document emailed within 1 workday
Related Documents
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425Floru, L.; Tegeler, J. 1974: Therapeutic significance of the beta-receptor blockade in lithium-induced tremor. Therapeutic trials with Pindolol and Practolol Die Medizinische Welt 25(11): 450
Clara, L.O.; Biglia, M.A. 1999: Pharmacokinetics of trovafloxacin: its clinical significance Medicina 59(Suppl): 17-22
Dubbels, R. 1983: Significance of pharmacokinetics in general medicine Zfa. Zeitschrift für Allgemeinmedizin 59(14): 823-827
Winne, D. 1971: The significance of blood drainage for the pharmacokinetics of intestinal absorption Die Medizinische Welt 16: 632 Passim
Paxton, J.W. 1981: Therapeutic drug monitoring and clinical pharmacokinetics Australian and New Zealand Journal of Medicine 11(5): 558-561
Bergogne-Bérézin, E. 1996: Therapeutic applications of tissue pharmacokinetics of antibiotics Presse Medicale 25(8): 408
Wiedemann, G.J.; Siemens, H.J.; Mentzel, M.; Biersack, A.; Wössmann, W.; Knocks, D.; Weiss, C.; Wagner, T. 1993: Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide Cancer Research 53(18): 4268-4272
Boĭko, S.S.; Zherdev, V.P.; Neznamov, G.G. 1991: The role of bemitil pharmacokinetics in realizing its therapeutic efficacy Farmakologiia i Toksikologiia 54(2): 64-66
Bouvier, N.; Millart, H. 1998: Pharmacokinetics of beta blockers in hyperthyroidism. Therapeutic relevance Therapie 53(6): 523-531
Sariev, A.K.; Zherdev, V.P.; Sologova, S.S.; Litvin, A.A.; Rodionov, A.P.; Kolyvanov, G.B.; Vasil'ev, A.E. 1999: Cytisine pharmacokinetics when used in a transdermal therapeutic system in rabbits Eksperimental'naia i Klinicheskaia Farmakologiia 62(6): 59-61
Brøsen, K. 1991: The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs Ugeskrift for Laeger 153(6): 417-422
Bopp, S.; Marre, R.; Schulz, E.; Sack, K. 1981: Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin Arzneimittel-Forschung 31(3): 473-477
Cheymol, G. 1993: Pharmacokinetics and therapeutic monitoring of cyclosporine in liver transplant patients Annales de Gastroenterologie et d'Hepatologie 29(2): 81-85
Breyer, S.; Graninger, W.; Hitzenberger, G. 1980: Pharmacokinetics, tolerance and therapeutic effect of trimethoprim-sulfametrol-infusions Wiener Medizinische Wochenschrift 130(12): 448-450
Budanov, S.V.; Smirnova, L.B. 2001: Levofloxacin (Tavanic)--a novel quinolone of the IIi generation. Antimicrobial activity, pharmacokinetics, clinical significance Antibiotiki i Khimioterapiia 46(5): 31-38
Petitjean, A.; Astier, A.; Louchahi, M.; Perret, G.; Karsenti, P.; Jacquot, C.; Petitjean, O. 1983: Pharmacokinetics of gentamicin in the decompensed alcoholic cirrhotic patient. Therapeutic consequences Pathologie-Biologie 31(5): 399-403
Litvin, A.A. 2004: Experimental pharmacokinetics of phenazepam during transdermal administration of the therapeutic phenaperkuten system Eksperimental'naia i Klinicheskaia Farmakologiia 67(2): 59-62
Jullien, V.; Lortholary, O. 2006: Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring Therapie 61(3): 209-217
Baron, S.; Raux Demay, M.C.; Vasmant, D.; Bensman, A. 1988: Pharmacokinetics of prednisolone in children. Study of a correlation with tolerability and therapeutic effect in nephrosis Presse Medicale 17(13): 632-635